Back to search

Article

Investigating Potential Inhibitory Effect of <em>Uncaria tomentosa</em> (Cat's claw) against the Main Protease 3CL<sup>Pro</sup> of SARS-CoV-2 by Molecular Modeling

2020-06-28

Abstract excerpt

COVID-19 is a novel severe acute respiratory syndrome coronavirus. Presently, there is no effective treatment for COVID-19. As part of the worldwide efforts to find efficient therapies and preventions, it has been reported the crystalline structure of the SARS-CoV-2 main protease Mpro (also called 3CLpro) bound to a synthetic inhibitor which represents a major druggable target. The druggability of Mpro could be us...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5330b517-8b98-50e0-ae42-a759f01fca25
DOI
10.20944/preprints202006.0326.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Investigating Potential Inhibitory Effect of <em>Uncaria tomentosa</em> (Cat's claw) against the Main Protease 3CL<sup>Pro</sup> of SARS-CoV-2 by Molecular ModelingDOI 10.20944/preprints202006.0326.v1
Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approachesSemantic proximity
Phytoconstitutents from Indian medicinal plants show therapeutic potential to combat COVID-19 by bind to SARS CoV-2 Main Protease (Mpro)Semantic proximity
Structure Based Screening Of Fungal Bioactive Metabolites As Potential Inhibitors Of Main Protease (Mpro) Of SARS-CoV-2Semantic proximity
Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approachSemantic proximity
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicinesSemantic proximity
Natural compounds as potential inhibitors of novel coronavirus (COVID-19) main protease: An in silico studySemantic proximity
Evaluation of the inhibitory potential of Bioactive compounds against SARS-CoV2 by in-silico approachSemantic proximity
In Silico Molecular Docking and Molecular Dynamic Simulation of Potential Inhibitors of 3C-like Main Proteinase (3CLpro) from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Using Selected African Medicinal PlantsSemantic proximity
Select a neighboring publication to make it the new centre.